Drug Price Trends for ROBAFEN

Average Pharmacy Cost for ROBAFEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
ROBAFEN CF LIQUID	00904-6537-20	0.02102	ML	2025-02-19
ROBAFEN DM 200-20 MG/20 ML LIQ	00904-7441-20	0.01953	ML	2025-02-19
ROBAFEN DM 200-20 MG/20 ML LIQ	00904-7223-20	0.01953	ML	2025-02-19
ROBAFEN DM 200-20 MG/20 ML LIQ	00904-7223-59	0.01636	ML	2025-02-19
ROBAFEN DM 200-20 MG/20 ML LIQ	00904-7223-59	0.01630	ML	2025-01-22
ROBAFEN 200 MG/10 ML SYRUP	00904-6763-20	0.02316	ML	2025-01-22
ROBAFEN CF LIQUID	00904-6537-20	0.02118	ML	2025-01-22

Market Analysis and Price Projections for Robafen

Introduction to Robafen

Robafen, a brand name for guaifenesin, is an expectorant commonly used to treat coughs and help loosen phlegm (mucus) in the bronchial tubes. It is often combined with other ingredients like dextromethorphan to create cough suppressant and expectorant formulations.

Market Overview of Cough Suppressant Drugs

The global cough suppressant drugs market, which includes products like Robafen, has been growing steadily. Here are some key points:

• Market Size and Growth: The global cough suppressant drugs market was valued at US$ 1100.4 million in 2017 and is expected to grow at a CAGR of 3.7% from 2018 to 2026[1].
• Regional Dominance: North America is expected to hold a dominant position in this market, driven by frequent FDA approvals for new cough suppressant drugs[1].

Product Details and Uses

• Active Ingredients: Robafen contains guaifenesin, an expectorant, and sometimes dextromethorphan, a cough suppressant. For example, Robafen DM Max Non-Drowsy contains 200mg of guaifenesin and 10mg of dextromethorphan per 5 mL[4].
• Uses: Robafen is used to temporarily relieve cough due to minor throat and bronchial irritation, such as that occurring with a cold. It helps loosen phlegm and thin bronchial secretions to drain bronchial tubes[4].

Pricing and Cost Considerations

• Current Pricing: The cost for Robafen oral liquid (100 mg/5 mL) is around $10 for a supply of 118 milliliters, depending on the pharmacy. Generic versions are also available, which can be more cost-effective[2].
• Discounts and Patient Assistance Programs: There are various discount cards, coupons, and patient assistance programs available that can reduce the cost of Robafen. For instance, the Drugs.com Discount Card can save up to 80% on prescription and over-the-counter medications[2].

Market Drivers and Trends

• High Prevalence of Cough: Cough is a common reason for visits to primary care physicians, accounting for around 8% of all consultations globally. The annual prevalence of cough in the general population is approximately 10–33% globally, driving the demand for cough suppressant drugs[1].
• Regulatory Approvals: Frequent approvals of new cough suppressant drugs by regulatory bodies like the FDA are expected to drive market growth. For example, the FDA approval for Mucinex DM Maximum Strength in 2018 is a significant factor[1].
• Strategic Partnerships: Key players in the market are involved in strategic mergers and partnerships to develop, manufacture, and sell novel cough suppressant drugs. This includes agreements like the one between Tris Pharma and Pfizer Consumer Healthcare[1].

Distribution Channels and Online Pharmacies

• Traditional Distribution: Cough suppressant drugs like Robafen are traditionally sold through pharmacies and retail stores.
• Online Pharmacies: The rise of online pharmacies is changing the distribution landscape. The global online pharmacy market is expected to grow significantly, driven by factors such as increased adoption of digital health services and the convenience of online shopping. This market was valued at USD 82.91 billion in 2023 and is expected to reach USD 294.35 billion by 2030, growing at a CAGR of 17.26%[3].

Safety and Regulatory Considerations

• Safety Labeling Changes: In January 2018, the FDA made safety labeling changes to limit the use of codeine or hydrocodone containing prescription opioid cough and cold medicines in children younger than 18 years old. This has impacted the pediatric use of certain cough suppressants but does not directly affect Robafen, which is primarily an expectorant[1].

Competitive Landscape

• Key Players: The market includes key players such as Perrigo Company plc, Vernalis plc, Tris Pharma Inc., Pfizer Inc., and others. These companies are actively involved in developing and marketing new cough suppressant drugs[1].

Price Projections

Given the steady growth in the cough suppressant drugs market and the increasing demand driven by high prevalence of cough, here are some price projection insights:

• Stable Pricing: The prices of Robafen and similar products are expected to remain relatively stable due to the availability of generic versions and competition in the market.
• Cost Savings: Online pharmacies and discount programs are likely to continue offering cost savings, which could slightly reduce the average price paid by consumers.
• Market Growth: As the market grows, the overall revenue from Robafen and similar products is expected to increase, but the per-unit price may not rise significantly due to competitive pressures.

Key Takeaways

• Growing Market: The global cough suppressant drugs market is growing, driven by high prevalence of cough and frequent regulatory approvals.
• Stable Pricing: Prices for Robafen are expected to remain stable due to competition and the availability of generic versions.
• Online Distribution: The rise of online pharmacies is likely to impact distribution channels and offer more convenient and cost-effective options for consumers.
• Regulatory Compliance: Safety labeling changes and regulatory approvals will continue to shape the market.

Frequently Asked Questions (FAQs)

1. What is Robafen used for? Robafen is used to temporarily relieve cough due to minor throat and bronchial irritation and to help loosen phlegm (mucus) in the bronchial tubes.

2. What are the active ingredients in Robafen DM Max Non-Drowsy? The active ingredients are dextromethorphan hydrobromide (10mg in 5mL) and guaifenesin (200mg in 5mL).

3. How much does Robafen typically cost? The cost for Robafen oral liquid (100 mg/5 mL) is around $10 for a supply of 118 milliliters, depending on the pharmacy.

4. Are there any discount programs available for Robafen? Yes, there are various discount cards, coupons, and patient assistance programs available that can reduce the cost of Robafen.

5. How is the rise of online pharmacies affecting the distribution of cough suppressant drugs? The rise of online pharmacies is providing more convenient and cost-effective options for consumers, with frequent discounts and subscription models, which is expected to drive market growth.

Cited Sources

1. Coherent Market Insights: "Cough Suppressant Drugs Market - Price, Size, Share & Growth"
2. Drugs.com: "Robafen Prices, Coupons, Copay Cards & Patient Assistance"
3. GlobeNewswire: "Online Pharmacy Market Report 2024, with Forecasts to 2030"
4. Drugs.com: "Robafen DM Max Non drowsy (liquid) Major Pharmaceuticals"